Rheumatoid arthritis
Conditions
Interventions
Group 2:intravenous lidocaine infusion and glucocorticoid
Group 3:intravenous lidocaine infusion
Group 4:NSAIDS
Sponsors
Department of Pain, Guizhou Provincial People's Hospita
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Aged 18-65 years; (2) Diagnosed as rheumatoid arthritis; (3) The patient has signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Organic digestive tract diseases, such as peptic ulcer, gastrointestinal tumor, inflammatory bowel disease; (2) Patients with severe heart, liver, renal insufficiency, diabetes and other diseases; (3) Suffering from mental illness, including severe hysteria;Do not have independent ability (4) The product is allergic or intolerant (5) Women who are pregnant or nursing, or who are planning to become pregnant; (6) Participated in other clinical trials in the last 3 months (7) The drugs that affected the observation of this experiment were used 1 week before the inclusion, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, immunosuppressive drugs, anti-ulcer drugs, etc.; (8) Any medical history which, according to the researcher, may interfere with the test results or increase the risk of patients; (9) Researchers judge that compliance is not good, can not strictly implement the program.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS;DAS28;SDAI;ESR;CRP;RF;CCP;Glucocorticoid dosage;Analgesic dosage;Number of joint pain;Number of joint swelling; | — |
Countries
China
Contacts
Public ContactChunjing He
Guizhou Provincial People's Hospital
Outcome results
None listed